Vanta Bioscience Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was INR 62.76 million compared to INR 96.88 million a year ago. Revenue was INR 69.63 million compared to INR 101.11 million a year ago.

Net loss was INR 64.81 million compared to net income of INR 0.882 million a year ago. Basic loss per share from continuing operations was INR 10.27 compared to basic earnings per share from continuing operations of INR 0.14 a year ago. Diluted loss per share from continuing operations was INR 10.27 compared to diluted earnings per share from continuing operations of INR 0.14 a year ago.